Search Within

Jennifer Lynn Sauter

  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Meeting Abstract (23)
  2. Journal Article (18)
  3. Review (1)
Groups
  1. Department of Pathology and Laboratory Medicine (42)
  2. GSK Faculty (42)
  3. Human Oncology and Pathogenesis Program (42)
  4. Tow Center for Developmental Oncology (TCDO) (41)
  5. Department of Medicine (38)
  6. Solid Tumor Oncology Division (38)

More Groups

People
  1. Marc Ladanyi (41)
  2. William Travis (29)
  3. Marjorie Zauderer (24)
  4. Natasha Rekhtman (24)
  5. Jason Chang (22)
  6. Michael Offin (18)

More People

Years
  1. 2025 (2)
  2. 2024 (4)
  3. 2023 (2)
  4. 2022 (4)
  5. 2021 (9)
  6. 2020 (7)

More Years

Publications
  1. Modern Pathology (14)
  2. Laboratory Investigation (8)
  3. Journal of Thoracic Oncology (5)
  4. Journal of Clinical Oncology (4)
  5. Clinical Cancer Research (3)
  6. American Journal of Surgical Pathology (1)

More Publications

Publishers
  1. Nature Research (14)
  2. Nature Publishing Group (8)
  3. Elsevier Inc. (6)
  4. American Association for Cancer Research (4)
  5. American Society of Clinical Oncology (4)
  6. Annual Reviews (1)

More Publishers

Results (42)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Molecular correlates of PD-L1 expression in patients with non-small cell lung cancer
    Meeting Abstract

    Rizvi, H.; Bandlamudi, C.; Schoenfeld, A. J.; Sauter, J. L.; Arbour, K. C.; Beras, A.; Egger, J. V.; Ladanyi, M.; Donoghue, M.; Rudin, C. M.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Prevalence and preliminary validation of screening criteria to identify carriers of germline BAP1 mutations
    Journal Article

    Zauderer, M. G.; Jayakumaran, G.; DuBoff, M.; Zhang, L.; Francis, J. H.; Abramson, D. H.; Cercek, A.; Nash, G. M.; Shoushtari, A.; Chapman, P.; more...
    Journal of Thoracic Oncology (2019)

    Fulltext@MSK | Save
  • Evaluation of H3K27me3 expression as a marker of EZH2 activation in SMARCA4/SMARCA2-deficient tumors and candidate biomarker for trials of EZH2 inhibitors
    Meeting Abstract

    Kezlarian, B.; Montecalvo, J.; Sauter, J.; Travis, W.; Gounder, M.; Rudin, C.; Ladanyi, M.; Namakydoust, A.; Rekhtman, N.
    Modern Pathology (2019)

    Fulltext@MSK | Save
  • Evaluation of H3K27me3 expression as a marker of EZH2 activation in SMARCA4/SMARCA2-deficient tumors and candidate biomarker for trials of EZH2 inhibitors
    Meeting Abstract

    Kezlarian, B.; Montecalvo, J.; Sauter, J.; Travis, W.; Gounder, M.; Rudin, C.; Ladanyi, M.; Namakydoust, A.; Rekhtman, N.
    Laboratory Investigation (2019)

    Fulltext@MSK | Save
  • Clinical and molecular features predicting long-term response (LTR) to anti-PD-(L)1 based therapy in patients with NSCLC
    Meeting Abstract

    Rizvi, H.; Plodkowski, A. J.; Tenet, M.; Halpenny, D.; Long, N.; Sauter, J. L.; Sanchez-Vega, F.; Chatila, W. K.; Schultz, N.; Ladanyi, M.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • VISTA is highly expressed in malignant pleural mesothelioma (MPM) and independent of PD-L1 expression
    Meeting Abstract

    Zauderer, M.; Muller, S.; Lai, W.; Ni, A.; Jungbluth, A.; Ginsberg, M.; Daly, R.; Hellmann, M.; Ladanyi, M.; Sauter, J.
    Journal of Thoracic Oncology (2018)

    Fulltext@MSK | Save
  • Bronchiolar adenoma: Expansion of the concept of ciliated muconodular papillary tumors with proposal for revised terminology based on morphologic, immunophenotypic, and genomic analysis of 25 cases
    Journal Article

    Chang, J. C.; Montecalvo, J.; Borsu, L.; Lu, S.; Larsen, B. T.; Wallace, W. D.; Sae-Ow, W.; Mackinnon, A. C.; Kim, H. R.; Bowman, A.; more...
    American Journal of Surgical Pathology (2018)

    Fulltext@MSK | Save
  • SMARCA4 (BRG1) deficiency in lung carcinomas correlates with poor differentiation and aggressive clinical behavior
    Meeting Abstract

    Montecalvo, J.; Alex, D.; Ptashkin, R.; Ni, A.; Sauter, J. L.; Chang, J.; Beras, A.; Namakydoust, A.; Rudin, C.; Ladanyi, M.; more...
    Modern Pathology (2018)

    Fulltext@MSK | Save
  • Pulmonary BRG1 (SMARCA4)-deficient undifferentiated neoplasms represent an exceptionally aggressive type of sarcomatoid carcinoma: Clinicopathologic and genomic evidence supports a link to non-small cell carcinoma
    Meeting Abstract

    Montecalvo, J.; Alex, D.; Ptashkin, R.; Ni, A.; Sauter, J. L.; Chang, J.; Jungbluth, A.; Beras, A.; Namakydoust, A.; Rudin, C.; more...
    Modern Pathology (2018)

    Fulltext@MSK | Save
  • Prominent expression of the negative immune checkpoint regulator VISTA in malignant pleural mesothelioma (MPM)
    Meeting Abstract

    Muller, S.; Zauderer, M.; Desmeules, P.; Jungbluth, A.; Fayad, M.; Frosina, D.; Ni, A.; Ladanyi, M.; Sauter, J. L.
    Modern Pathology (2018)

    Fulltext@MSK | Save